Nabriva Therapeutics

$0.4355
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.012 (+2.85%) Today

+$0.0025 (+0.58%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell NBRV and other stocks, options, and ETFs commission-free!

About NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland, also called Nabriva Therapeutics, is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland. The listed name for NBRV is Nabriva Therapeutics plc Ordinary Shares Ireland.

CEO

Theodore R. Schroeder

Employees

162

Headquarters

Dublin, Dublin

Founded

2005

Market Cap

65.29M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.50M

High Today

$0.4469

Low Today

$0.4225

Open Price

$0.439

Volume

1.15M

52 Week High

$2.04

52 Week Low

$0.385

Collections

Research And Development

Pharmaceutical

NBRV Earnings

-$0.33

-$0.22

-$0.11

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours